Polypeptide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 10, 2009
Issued Date -
N/A
app pub date -
Mar 15, 2007
filing date -
Nov 18, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides 5T4 tumour-associated antigen (TAA) for use in a method of immunotherapy of tumours. The invention also relates to a recombinant poxvirus vector from which at least one immune evasion gene has been deleted, which comprises a nucleic acid sequence encoding a 5T4 TAA and the use thereof in vaccinating against and in treating tumours.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully